- Record: found
- Abstract: not found
- Article: not found
A phase II, double-blind, randomized multicenter study of cediranib with FOLFOX vs bevacizumab with FOLFOX in patients with previously treated metastatic colorectal cancer (mCRC): Final PFS results
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.